Product Information

NYLIA 7-7-7-28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2450 per EA under NDC 65862089788. Its NADAC has been published 255 times since Aug 11, 2021.

NYLIA 7-7-7-28 TABLET

Norethindrone and Ethinyl Estradiol
$0.2450per EA

NDC

65862089788

Classification

Generic

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207054

On Market Since

10/21/2016

Price Statistics

The NADAC for NYLIA 7-7-7-28 TABLET has been published 255 times since Aug 11, 2021, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2450 per EA
All-time high$0.5336 (Feb 15, 2023)
All-time low$0.1916 (Nov 20, 2024)
52-week high$0.2985
52-week low$0.2444
Median price$0.2934
Average price$0.3123
Largest weekly change-36.8% (May 17, 2023)
Weeks tracked255
Tracking sinceAug 11, 2021

Price History

1W

0.0%

1M

-4.5%

3M

-17.3%

6M

-15.4%

1Y

-0.6%

3Y

-18.5%

5Y

N/A

All

-34.3%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NYLIA 7-7-7-28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NYLIA 7-7-7-28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.2450 per EA (NDC 65862089788), effective Jun 24, 2026.

How has the price of NYLIA 7-7-7-28 TABLET changed over time?

Over the history we have for it, the NADAC for NYLIA 7-7-7-28 TABLET has declined 34.3%. It has been tracked across 255 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for NYLIA 7-7-7-28 TABLET?

Since Aug 11, 2021, the NADAC for NYLIA 7-7-7-28 TABLET has ranged from a low of $0.1916 (Nov 20, 2024) to a high of $0.5336 (Feb 15, 2023), with a median of $0.2934 per EA.

Are there cheaper alternatives to NYLIA 7-7-7-28 TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2063 per EA — about 16% below NYLIA 7-7-7-28 TABLET.

Who manufactures NYLIA 7-7-7-28 TABLET?

NYLIA 7-7-7-28 TABLET (NDC 65862089788) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.